Henry Schein (HSIC) Reports $400M Increase in Buyback Plan

Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that its Board of Directors has authorized the repurchase of up to $400 million of shares of the Company's common stock. This program is in addition to the $300 million repurchase program announced in December 2014, which as of today has approximately $25 million remaining authorized for future repurchases.

The Company had approximately 83 million shares outstanding as of October 26, 2015, and this new authorization represents approximately 3.0% percent of shares outstanding at the current stock price. Purchases may be made from time to time in the open market, or through negotiated transactions.

"Henry Schein's share repurchase program demonstrates our long-term commitment to increasing shareholder value, and reflects our confidence in the long-term prospects of our business," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "We are pleased that Henry Schein's strong balance sheet provides us with the financial flexibility to return capital to our shareholders, while also making investments in our company that capitalize on future growth opportunities."

You May Also Be Interested In

• Swiss Water gets TSX nod to buy back up to 650,000 shares
• Almonty Industries launches $300M share repurchase program
• Savers Value Village closes 23M share secondary offering